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ABSTRACT
INTRODUCTION: The article discusses the use of dexamethasone as an adjuvant to local anesthetic solu-
tion for ultrasound (US)-guided femoral nerve block in patients after total knee joint replacement. A litera-
ture review on the clinical use of other adjuvants is also presented.
DESIGN: This was a clinical prospective randomized study.
AIM: The aim of this article is to investigate the effect of dexamethasone adjuvant on the local anesthetic 
solution when performing a US-guided femoral block in patients after total knee joint replacement.
METHODS: The study included 53 patients, randomized into two groups: Group 1: single shot femoral 
nerve block (FNB) + constant infusion through a perineural catheter 15 mL bolus (ropivacaine 0.5%/levobu-
pivacaine 0.375%) with a subsequent infusion of 5-9 mL per hour, including 20 patients; Group 2: single 
shot FNB 20 mL bolus (ropivacaine 0.5%/levobupivacaine 0.375%) ± dexamethasone 4 mg, including 33 pa-
tients. In Group 2, 2 subgroups were formed: patients with single shot FNB with chirocain – 10 patients; pa-
tients with single shot FNB with ropivacaine – 23 patients. Of these, 15 patients were fasted with single shot 
FNB  with ropivacaine + dexamethasone 4 mg, and 8 patients with pure ropivacaine.
Evaluation of effective control of pain relief symptoms was done on 2nd, 4th, 6th, 12th, 18th, 24th, and 36th hours 
postoperatively according to the Visual Analogue Scale (VAS).
RESULTS: No statistically significant difference in VAS scores was observed between the two groups in the 
2nd, 6th, 12th, 18th and 36th hours. Such was found only in the 24th hour. We did not detect statistically signifi-
cant benefits of this adjuvant. We do not have clinically registered adverse drug reactions (ADRs). We have 
not established a correlation between these occurrences and the use of dexamethasone.
CONCLUSION: Although our results correspond to those of authors who refute the benefits of dexameth-
asone as an adjuvant to the peripheral nerve block (PNB), we believe, based on clinical observation data, 
that it actually attenuated reversible hyperalgesia 
(patients did not report abruptly, acute, sudden on-
set of pain), therefore prolongation of the analgesic 
effect was observed until the 18th, 20th postoperative 
hour.
Keywords: dexamethasone, adjuvant, US-guided 
femoral block, postoperative pain relief, knee joint, 
total knee joint replacement
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corded complications in the implementation of pe-
ripheral nerve blocks.
When performing a peripheral nerve block, sin-
gle shot or continuous infusion through a perineural 
catheter in modern anesthesia is recommended, two 
local anesthetics are recommended to be instilled - 
levobupivacaine and ropivacaine. Their widespread 
popularity in contemporary regionalism is due to 
their safe profile in continuous infusion, lower car-
diotoxicity and hemodynamic stability with lido-
caine and bupivacaine, lack of neurotoxicity and de-
myelinating processes (1,2) and, of course, their pro-
longed effect.
Numerous reports and studies to compare an-
algesic potency, duration, concomitant motor block 
to determine optimal local anesthetic, concentration, 
bolus volume, and speed and infusion concentration 
are present in the literature.
With regard to the addition of adjuvants to the 
local anesthetic, the use of vasoconstrictors is ob-
served due to the risk of ischemic damage to the pe-
ripheral nerves caused by vasoconstriction of vasa 
nervorum.
The results for clonidine and dexmedetomidine 
are controversial, both in terms of the potential and 
prolonging effects, the occurrence of frequent unde-
sirable hypotensive (3), and in case of doubt about the 
possible toxic effect of clonidine in peripheral nerves 
experimentally in animals.
More good results in the literature refer to dex-
medetomidine (4). Clinical trials establish a real pro-
longation of peripheral nerve blocks (PNBs) with the 
addition of 100 mcg of dexmedetomidine to a local 
anesthetic but there is frequent bradycardia requir-
ing medication (5).
Absolute apogee in the literature was observed 
with the discovery of beneficial and potentiating ef-
fects of dexamethasone, administered both as an ad-
juvant to the local anesthetic in single shot PNBs and 
in direct intravenous application (6,7,8).
Applied as an adjuvant, a significantly pro-
longed analgesic effect over 200 minutes and better 
results in the evaluation of postoperative pain on val-
idated scales (VAS) (9,10,11,12) is registered. In the 
last 2-3 years, the addition of dexamethasone ad-
juvant to a solution of a long-acting local anesthet-
ic in performing PNBs is a tendency to avoid peri-
INTRODUCTION
“The art of life is the art of avoiding pain”
Thomas Jefferson
Optimal control of perioperative pain contin-
ues to be a major challenge for physicians, anesthe-
tists, intensive care specialists and surgeons. It allows 
the reduction of patient suffering and maximum sat-
isfaction, early mobilization, shortened hospital stay, 
reduced registered complications, morbidity and 
mortality.
Major surgery is associated with severe periop-
erative stress on the body, reflecting both the phys-
ical condition as well as the psychological aspect of 
the individual and the quality of life of the patient.
Effective pain control in the perioperative and 
early postoperative period has a lower incidence of 
complications such as postoperative respiratory fail-
ure, deep vein thrombosis and pulmonary thrombo-
embolism, lower cardiac risk, nosocomial infections, 
and postoperative delirium. Good pain control re-
sults in reduced hospital stays leading to the corre-
sponding economic benefits and, last but not least, a 
better quality of life.
Ultrasound (US)-guided nerve blocks are a 
modern, safe, reliable method for perioperative and 
postoperative analgesia that allows the reduction of 
the use of more invasive methods - epidural analge-
sia, drastic reduction of doses of the applied opiates 
with all the resulting negative effects - nausea, vom-
iting, itching, constipation, attenuated immunologi-
cal response, respiratory depression, sleepiness, etc.
Peripheral nerve block of n. femoralis under US 
control is a modern method allowing good periop-
erative pain control, early physiotherapy and mobili-
zation, a lower incidence of postoperative complica-
tions observed in patients after prosthetic knee joint 
replacement. All of the above-mentioned benefits 
make it a preferential method for postoperative an-
algesia in the early postoperative period. It provides 
a low-risk blockade with no absolute contraindica-
tions. It is also applied in patients with coagulation 
disorders.
US navigation allows a modern, fast, non-trau-
matic and reliable method, a low frequency of re-
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neural catheters as a more invasive method related 
to the risk of infection, nerve damage, frequent dis-
location and migration into other anatomical spaces. 
Other drawbacks of catheter techniques are the high-
er cost, the requirement of a particular logistics orga-
nization, and more highly skilled staff, respectively.
Ethiopathogenetically, the effect of dexameth-
asone is most likely due to induced vasoconstriction 
and prolongation of local anesthetic activity and, on 
the other hand, to reduced nociceptive sensitivity of 
C-fibers through direct effect on glucocorticoid re-
ceptors and inhibition of potassium channels, and 
possible systemic anti-inflammatory effect (13,14). 
Dexamethasone primarily affects dynamic 
pain, and its use does not increase the risk of wound 
infection (15).
In 2015, Ke An and co-authors (16) cite other 
possible beneficial effects of dexamethasone added 
as an adjuvant. They reported transient neurotoxic 
activity and reduced reversible hyperalgesia follow-
ing depletion of the block effect. Others, like Fred-
rickson Fanzca MJ and co-authors, consider that all 
these claims are subject to reassessment and the data 
on the described effects are not convincing enough 
(17,18).
Regarding the dose of dexamethasone as an ad-
juvant to a local anesthetic solution, the majority of 
the authors consider that the higher dose does not 
lead to a greater prolongation of the blockade or bet-
ter analgesia, but only increases the risk of system-
ic effects of corticosteroids. Doses of 4 mg and 8 mg 
dexamethasone were compared, with no significant 
difference in the quality of the block (9).










Fredrickson Analgesic quality and duration
Increased analge-
sia at 24h vs. no 
change at 48h

































Movafegh Analgesic duration Prolonged 242 ±76 vs. 98±33min       Nil noted
Parington Analgesic duration Prolonged  332 vs. 228 min    




Shrestha Analgesic duration Prolonged 1028 vs.453.17 min    
Superior to tra-
maol as regional 
adjuvant
Nil noted
Shrestha Analgesic quality and duration
Prolonged 834 vs. 
274 min No difference  
Faster onset of an-










48h. No significant 
difference between 
the two dexameth-
asone dosages with 
regard to outcome
Nil noted at 4 
weeks of follow-up
Table 1. Studies that examine the effect of dexamethasone as an adjunct to regional techniques dexamethasone with 
one-way results (19)
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The use of dexamethasone as part of a multi-
modal pain management strategy has been the sub-
ject of much discussion in recent years. Almost all 
clinicians are behind the fact that it most likely af-
fects the management of pain. Questions are asked 
about its intravenous application, whether epidural 
or perineural application is better, or what the dos-
age and duration of application should be. There are 
questions about the the exact mechanism of action, 
and the existence of adverse effects - early or late 
ones. Authors cite that, applied intravenously, dexa-
methasone again prolongs the effect of peripheral 
nerve blockade (20).
In 2016, Chun EH et al. conducted a study of 
two groups of patients who had an intercellular block 
for arthroscopic surgery on the shoulder joint. Dexa-
methasone 5 mg is used on both groups - intrave-
nously on one, and perineurally on the other. The re-
sults that they cite are definitely in favor of perineural 
application of dexamethasone, only there is a signif-
icant prolongation of the block with approximately 
200 min. Another study done with 4 mg dexameth-
asone with one-way results (19) is similar in design.
Some authors share good results in knee re-
placement patients who received ketamine intrave-
nous infusion 3mcg/kg/min intraoperatively and 
1.5mcg/kg/min 48h postoperatively. Ketamine influ-
ences the intensity of pain as well as prevents cen-
tral pain sensitization. The use of ketamine reduc-
es morphine consumption and shortens the time for 
patients to achieve 90 degrees of flexion on the knee 
joint. These authors suggest its application to region-
al femoral block (FB) techniques or epidural analge-
sia (21,15).
Several reports in the literature on topic adju-
vants to local anesthetics commented on magnesium 
sulphate as a prolonged PNB agent and better results 
on the visual acuity scale (VAS) pain assessment and 
a total dose of added analgesics (22,23). Magnesium 
demonstrates an antinociceptive effect in animal 
models and in humans. The antinociception effect is 
due to regulation of calcium influx. In the literature, 
there are various design studies where magnesium 
has been applied epidurally and the authors have reg-
istered a beneficial effect after its use with regard to 
opioid consumption and the extent of pain reported, 
i.e. co-administration of magnesium results in a bet-
ter analgesic effect (24,25).
A study from 2008 compares three control 
groups of patients with femoral perineural cathe-
ters infused with 0.2% ropivacaine 0.2%, ropivacaine 
0.2% + fentanyl 4 μg/mL and ropivacaine 0.2% + 50 
mg/mL, respectively. The authors report a better and 
prolonged analgesic effect in the two adjuvants of 
fentanyl and magnesium, respectively, with the re-
sults in both groups being comparable (26).
Other authors deny the antinociceptive effect 
of fentanyl administered perineurally, indicating no 
significant difference in the outcome (27).
It is still unclear in the literature whether peri-
neural application of an opioid (fentanyl) has a bene-
ficial effect on PNBs. Clinicians share a potentiating 
analgesic potency of 100 mcg of fentanyl added to a 
local anesthetic while performing an axillary block. 
They report a significant difference in the degree of 
analgesia, but also share a delayed onset of the block, 
as the most likely cause of this fact indicates a de-
crease in the pH of the fentanyl solution (28).
Until now, no theoretical rationale for the possi-
ble mechanism of action of perineural application of 
opioid has been found in the literature. In the axonal 
membrane of the afferent peripheral, nerve opioid re-
ceptors are absent. Following the physiological and 
pathophysiological mechanisms, the use of an opi-
oid adjuvant to a local anesthetic for peripheral nerve 
blocking appears to be illogical (29).
It is very likely that the superficial analgesic 
effect reported, which in some patients is observed 
to be due to the systemic action of the opioid rather 
than the local one. To confirm a possible peripheral 
effect of opiates, sophisticated preclinical and clini-
cal studies should be performed to justify the physi-
ological and pathophysiological justification of pos-
sible beneficial results (27).
Studies comparing potential beneficial effects 
and possible neurotoxicity and other adverse effects 
do not support regular use in daily medical practice 
as adjuvants to local anesthetics, midazolam, mag-
nesium, dexmedetomidine, and ketamine (30). Oth-
er authors set the question whether the addition of 
any adjuvant places the patient at an unnecessary 
risk without a certain benefit (30).
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At the moment, in the official marketing au-
thorizations of all the adjuvants discussed above, the 
perineural method of administration of the medica-
tion is not present (31).
AIM
The aim of this article is to investigate the ef-
fect of a dexamethasone adjuvant on the local anes-
thetic solution when performing a US-guided femo-
ral block in patients after knee joint replacement.
MATERIALS AND METHODS
The scientific study was conducted at the Anes-
thesiology and Intensive Care Clinic and in the Or-
thopedic Clinic of the St. Marina University Hospital 
in the period from 2012 until 2017.
All patients treated in the Anesthesiology and 
Intensive Care Clinic were fasted by one of the fol-
lowing methods:
  Femoral block - long infusion through perineu-
ral catheter + NE opioid + SOS opioid.
  Single shot femoral block + NE opioid + SOS 
opioid.
Two groups were formed, one of which with 
two subgroups:
Group 1: single shot FNB + constant infusion 
through a perineural catheter 15 mL bolus (ropiva-
caine 0.5%/levobupivacaine 0.375%) with a subse-
quent infusion of 5-9 mL per hour. The group con-
sisted of 20 patients.
Group 2: single shot FNB 20 mL bolus (ropi-
vacaine 0.5%/levobupivacaine 0.375%) ± dexametha-
sone 4 mg. The group consisted of 33 patients. In this 
group, 2 subgroups were formed: patients with single 
shot FNB with chirocain – 10 patients; patients with 
single shot FNB with ropivacaine – 23 patients. Of 
these, 15 patients were fasted with single shot FNB 
with ropivacaine + dexamethasone 4 mg, 8 patients 
with pure ropivacaine.
Evaluation of effective control of pain relief 
symptoms on 2nd, 4th, 6th, 12th, 18th, 24th, and 36th 
hours postoperatively was done according to VAS.
RESULTS 
Comparison of the results in the VAS score in 
the two groups: Group 1 - single shot FNB + constant 
infusion through perineural catheter and Group 2 - 
single shot FNB ± dexamethasone.
No statistically significant difference in VAS 
values was observed with the use of a catheter in the 
2nd, 6th, 12th, 18th and 36th hours. Such was found only 
in the 24th hour.
The curves practically overlap until the 18th 
hour, after which the patients with perineural cathe-
ter and a constant infusion of local anesthetic show a 
lower VAS score at the 24th and 36th hour.
Statistically significant is the difference only at 
the 24th hour. Our results reported an advantage of 
the catheter technique after the 18th hour, the differ-















Mann-Whitney U 319,500 320,500 315,000 292,500 214,000 252,500
Wilcoxon W 529,500 881,500 525,000 502,500 424,000 462,500
Z -,296 -,344 -,334 -,787 -2,372 -1,663
Asymp. Sig. (2-tailed) ,767 ,731 ,738 ,431 ,018 ,096
a. Grouping Variable: Perineural catheter
Table 2. VAS score in both subgroups with/without perineural catheter
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ence being statistically significant at 24h. The same 
was the conclusion of Francis Salinas et al. in 2006.
It should be noted that the 24th postoperative 
hour is the time for starting verticalization and re-
habilitation of the patients in the Orthopedic Clinic 
at the St. Marina University Hospital, i.e. the muscu-
lar weakness of m. quadriceps femoris would be un-
desirable at this time.
Such a view of “single shot” preference tech-
nique is expressed in the Heeremans EH et al., 2012. 
Adding the higher price, time consumption, the re-
quirements for higher qualification of the service 
staff (32), we think that for primary prosthesis the 
single shot FNB technique is more appropriate, with 
a view to early patient verticalization and rehabilita-
tion, an early post-operative period outside of Anes-
thesiology and Intensive Care Clinic and a lower in-
fection risk. Permanent catheter techniques are be-
lieved to be suitable for secondary and tertiary in-
terventions that are more traumatic in which pa-
tients are in an Anesthesiology and Intensive Care 
Clinic and in which early verticalization and reha-
bilitation do not begin because of joint instability.
Effect of Dexamethasone on VAS Score
In 2015, based on the literature, we decided to 
start administering 4 mg of dexamethasone to the lo-
cal anesthetic solution at the time of the PNB. In this 
study, 15 patients in the single shot FNB group + rop-
ivacaine had dexamethasone added as an adjuvant. 
Data processing reported a statistically significant 
difference after the 18th hour, also in the 24th and 36th, 
but they did not in benefit from dexamethasone (Fig. 
2). The reported difference was a minimum <0.5 of 
the VAS score, which is within the error of the inqui-
ry method and is of no clinical significance. We did 
not detect statistically significant benefits of this ad-
juvant. We did not have clinically registered ADRs. 
We have not established a correlation between these 
occurrences and the use of dexamethasone.
A statistically significant difference was ob-
served in the 24th and 36th hours, and after the 18th 
hour.
CONCLUSION 
Although our results correspond to those of au-
thors who refute the positives of dexamethasone (12, 
25) as an adjunct to PNB, we believe, based on clin-
ical observation data, that it actually attenuated re-
versible hyperalgesia (patients did not report abrupt, 
acute, sudden onset of pain), therefore prolongation 
of the analgesic effect was observed until the 18th, 20th 
postoperative hour.
However, the number of patients and the vali-
dated scales we used did not show statistically signif-














Mann-Whitney U 270,500 267,000 254,000 225,500 153,000 170,000
Wilcoxon W 390,500 387,000 374,000 966,500 894,000 911,000
Z -.440 -.701 -.743 -1.343 -2.905 -2.656
Asymp. Sig. (2-tailed) .660 .483 .458 .179 .004 .008
a. Grouping Variable: Dexamethasone to LA
Table 3. Median VAS score in patients anesthetized with PNB ± dexamethasone
Fig. 2. Average VAS score in + (blue color)/- (red color) 
dexamethasone patients
*A large vertical chart magnification is applied because of the 
minimum difference in the parameter to better visualize
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